USA: Merck and other companies commit to end chimpanzee research
The major pharmaceutical company Merck & Co. has committed to no longer conduct or financially support research using chimpanzees. It has joined 26 other pharmaceutical companies and contract laboratories1 in phasing out chimpanzee research or restricting their use of chimpanzees by following the principles set forth by an Institute of Medicine report released in 2011 that assessed the necessity of chimpanzee research2. This report also led to the announcement of the National Institutes of Health in June 2013 that 90% of chimpanzees owned by the US government would be retired to sanctuaries (see ALTEX 30(3), 406).
Although their use is restricted but not banned by Directive 2010/63/EU, no great apes have been used for experimental purposes in the European Union since 1999.
back to overview